Position | Company | Period |
---|
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-04-03 | 2024-04-02 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
200
-14.3%
248,4549 690 USD |
200 -14.3% | 248,45 | 49 690 USD | |
2024-04-03 | 2024-04-02 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
43
-3.0%
247,0310 622 USD |
43 -3.0% | 247,03 | 10 622 USD | |
2024-04-03 | 2024-04-02 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
557
-27.9%
246,30137 187 USD |
557 -27.9% | 246,30 | 137 187 USD | |
2024-04-03 | 2024-04-02 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
2 991
-60.0%
244,89732 480 USD |
2 991 -60.0% | 244,89 | 732 480 USD | |
2024-04-03 | 2024-04-02 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
6 279
-55.7%
244,191 533 286 USD |
6 279 -55.7% | 244,19 | 1 533 286 USD | |
2024-04-03 | 2024-04-02 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
842
-7.0%
243,26204 821 USD |
842 -7.0% | 243,26 | 204 821 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
274
-18.6%
266,9173 132 USD |
274 -18.6% | 266,91 | 73 132 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
500
-25.4%
265,49132 743 USD |
500 -25.4% | 265,49 | 132 743 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
351
-15.1%
264,8992 977 USD |
351 -15.1% | 264,89 | 92 977 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
178
-7.1%
263,3146 870 USD |
178 -7.1% | 263,31 | 46 870 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
800
-24.2%
262,01209 604 USD |
800 -24.2% | 262,01 | 209 604 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
200
-5.7%
259,1151 822 USD |
200 -5.7% | 259,11 | 51 822 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
1 460
-29.4%
258,28377 094 USD |
1 460 -29.4% | 258,28 | 377 094 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
3 604
-42.1%
257,30927 302 USD |
3 604 -42.1% | 257,30 | 927 302 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
7 401
-46.4%
256,501 898 371 USD |
7 401 -46.4% | 256,50 | 1 898 371 USD | |
2024-04-03 | 2024-04-01 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
VP Vente planifiée |
6 809
-29.9%
255,641 740 630 USD |
6 809 -29.9% | 255,64 | 1 740 630 USD | |
2023-08-15 | 2023-08-14 |
Halozyme Therapeutics Inc
(HALO)
|
V Vente |
10 000
-32.8%
43,74437 410 USD |
10 000 -32.8% | 43,74 | 437 410 USD | |
2023-08-15 | 2023-08-11 |
Halozyme Therapeutics Inc
(HALO)
|
V Vente |
10 000
-24.7%
43,71437 110 USD |
10 000 -24.7% | 43,71 | 437 110 USD | |
2020-11-25 | 2020-11-25 |
Halozyme Therapeutics Inc
(HALO)
|
V Vente |
10 363
-33.0%
40,41418 800 USD |
10 363 -33.0% | 40,41 | 418 800 USD | |
2020-08-13 | 2020-08-13 |
Halozyme Therapeutics Inc
(HALO)
|
V Vente |
34 337
-52.3%
29,12999 893 USD |
34 337 -52.3% | 29,12 | 999 893 USD | |
2020-05-13 | 2020-05-11 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
V Vente |
26 250
-100.0%
51,131 342 178 USD |
26 250 -100.0% | 51,13 | 1 342 178 USD | |
2019-09-11 | 2019-09-09 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
V Vente |
400
-100.0%
38,3915 356 USD |
400 -100.0% | 38,39 | 15 356 USD | |
2019-09-11 | 2019-09-09 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
V Vente |
29 600
-98.7%
37,791 118 504 USD |
29 600 -98.7% | 37,79 | 1 118 504 USD |